Literature DB >> 23644734

Practice of laryngectomy rehabilitation interventions: a perspective from Australia.

Suren Krishnan1, Julia Maclean.   

Abstract

PURPOSE OF REVIEW: To provide a perspective of contemporary practice in rehabilitation of speech and swallowing in patients undergoing total laryngectomy in Australia. RECENT
FINDINGS: In Australia, the preferred method of voice rehabilitation is by the use of tracheo-oesophageal voice prosthesis. Dysphagia is an ongoing problem and the use of adjuvant radiation and chemotherapy compounds this problem. There are difficulties associated with surgery because of the variation in disease involvement of pharyngeal mucosa and musculature, as well as difficulties associated with healing in previously chemoradiated surgical fields.
SUMMARY: This article demonstrates the need for careful consideration of surgical technique, particularly in closure of the neopharynx in the chemoradiated patient. It encourages further research into the problems of speech and particularly swallowing in this patient population, as these problems impact significantly on the quality of life.

Entities:  

Mesh:

Year:  2013        PMID: 23644734     DOI: 10.1097/MOO.0b013e32836118aa

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  2 in total

1.  Affective symptoms and swallow-specific quality of life in total laryngectomy patients.

Authors:  Glen J F Kemps; Iris Krebbers; Walmari Pilz; Sophie Vanbelle; Laura W J Baijens
Journal:  Head Neck       Date:  2020-07-04       Impact factor: 3.147

Review 2.  Interdisciplinary interventions in the perioperative rehabilitation of total laryngectomy: an integrative review.

Authors:  Vitor Modesto Rosa; Joselia Maria Lira Fores; Erika Priscila Ferreira da Silva; Elizeteh Oliveira Guterres; Aline Marcelino; Paula Cristina Nogueira; Wania Regina Mollo Baia; Marco Aurélio Vamondes Kulcsar
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.